Table 1.
Choices of antiseptic products in the treatment of open wounds and awareness of evidence
| Professionals | Total (N) * | Chlorhexidine (%) | Eusol® (%) | Fucidin® (%) | Furacin® (%) | Honey (%) | Iodine (%) | Silver product (%) | Other (%) | |
|---|---|---|---|---|---|---|---|---|---|---|
| Surgeons | Usage | 24 | 13 (54) | 7 (29) | 6 (25) | 1 (4) | 6 (25) | 9 (38) | 9 (38) | 8 (33) |
| Evidence ** | 22 | 14 (64) | 6 (27) | 3 (14) | 4 (18) | 10 (45) | 9 (41) | 12 (55) | NA | |
| Plastic surgeons | Usage | 25 | 8 (32) | 13 (52) | 14 (56) | 8 (32) | 6 (24) | 8 (32) | 6 (24) | 1 (4) |
| Evidence ** | 25 | 12 (48) | 8 (32) | 11 (44) | 10 (40) | 9 (36) | 14 (56) | 9 (36) | NA | |
| Dermatologists | Usage | 37 | 15 (41) | 11 (30) | 19 (51) | 1 (3) | 2 (5) | 24 (65) | 21 (57) | 2 (5) |
| Evidence ** | 37 | 17 (46) | 7 (19) | 15 (41) | 1 (3) | 7 (19) | 14 (38) | 19 (51) | NA | |
| General practitioners | Usage | 8 | 3 (38) | 0 (0) | 6 (75) | 0 (0) | 1 (13) | 8 (100) | 3 (38) | 2 (25) |
| Evidence ** | 7 | 2 (29) | 1 (14) | 4 (57) | 1 (14) | 1 (14) | 4 (57) | 4 (57) | NA | |
| Specialised nurses | Usage | 57 | 6 (11) | 14 (25) | 11 (19) | 2 (4) | 31 (54) | 24 (42) | 47 (82) | 24 (40) |
| Evidence ** | 55 | 2 (4) | 11 (20) | 8 (15) | 3 (5) | 13 (24) | 35 (64) | 9 (16) | NA | |
| Surgical nurses | Usage | 65 | 27 (42) | 25 (38) | 13 (20) | 7 (11) | 15 (23) | 23 (35) | 37 (57) | 33 (51) |
| Evidence ** | 51 | 26 (51) | 14 (27) | 14 (27) | 7 (14) | 17 (33) | 25 (49) | 26 (51) | NA | |
| Home care nurses | Usage | 17 | 5 (31) | 6 (38) | 7 (44) | 0 (0) | 7 (44) | 9 (56) | 11 (69) | 2 (13) |
| Evidence ** | 15 | 5 (33) | 6 (40) | 4 (27) | 1 (7) | 8 (53) | 5 (33) | 8 (53) | NA | |
| Manufacturers | Usage | 23 | 2 (9) | 6 (26) | 4 (17) | 0 (0) | 13 (57) | 7 (30) | 20 (87) | 15 (65) |
| Evidence ** | 21 | 1 (5) | 1 (5) | 1 (5) | 0 (0) | 6 (29) | 14 (67) | 13 (62) | NA | |
NA, not applicable.
* N is total number of participants who answered the question.
**Evidence is number of respondents who have the opinion that the effectiveness of a particular product is evidence‐based.